Normal-Weight Obesity: Implications for Cardiovascular Health Nathalie JeanVirend K. SomersFrancisco Lopez-Jimenez Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 24 October 2014 Article: 464
Ivabradine, Coronary Heart Disease, and Heart Failure: Time for Reappraisal Tomáš ŠtulcRichard Češka Invited Commentary 10 October 2014 Article: 463
Interaction Between Pro12Ala Polymorphism of PPARγ2 and Diet on Adiposity Phenotypes Emanuela LapiceOlga Vaccaro Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 24 October 2014 Article: 462
Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease Piroze M. DavierwalaFreidrich W. Mohr Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 26 October 2014 Article: 461
The Role of Lifestyle Change for Prevention of Cardiovascular Disease in Diabetes Lisa R. StaimezMary Beth WeberEdward W. Gregg Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 04 November 2014 Article: 460
Endovascular Versus Medical Therapy for Atherosclerotic Renovascular Disease Mark Shipeng YuDavid A. FoltChristopher J. Cooper Clinical Trials and Their Interpretations (JR Kizer, Section Editor) 10 October 2014 Article: 459
Statins, Glycemia, and Diabetes Mellitus: Another Point of View Tomáš ŠtulcRichard Češka Invited Commentary 07 October 2014 Article: 458
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes Craig A. JohnstonJennette P. MorenoJohn P. Foreyt Nutrition (JP Foreyt, Section Editor) 07 October 2014 Article: 457